ClinicalTrials.Veeva

Menu

Ultrasonic Neuromodulation for Treatment of PTSD

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status and phase

Terminated
Phase 2
Phase 1

Conditions

PTSD

Treatments

Device: Diadem

Study type

Interventional

Funder types

Other

Identifiers

NCT06135064
IRB_00173062

Details and patient eligibility

About

This study will evaluate a new form of non-invasive deep brain therapy for individuals with post-traumatic stress disorder (PTSD). Low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychophysical and physiological monitoring. A well-tolerated stimulation protocol will be selected for subsequent testing in a blinded randomized sham-controlled cross-over trial. The trial will evaluate brain target engagement using magnetic resonance imaging and numerical scales of PTSD, cognitive performance, and mood.

Enrollment

10 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Positive PTSD diagnosis; PCL-5 > 20

Exclusion criteria

  • Inability to complete MRI
  • Suicidal ideation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

10 participants in 2 patient groups

Active stimulation
Experimental group
Description:
Low-intensity transcranial focused ultrasound stimulation of deep brain targets affected by PTSD.
Treatment:
Device: Diadem
Sham stimulation
Sham Comparator group
Description:
Sham stimulation that applies the device in the same way as verum but only delivers auditory sounds correspoding to the ultrasonic pulses.
Treatment:
Device: Diadem

Trial contacts and locations

1

Loading...

Central trial contact

Jan Kubanek, PhD; Elisabeth Wilde, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems